Eki Schutz
Chief Science Officer
Replay available
Oncocyte Corporation (OCX) Q1 2025 Earnings Call
Oncocyte Corporation (NASDAQ: OCX) Q1 2025 earnings conference call, held 2025-05-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Andrea James
Chief Financial Officer
Josh Riggs
President and CEO
Thomas Flatton
Analyst, Lake Street
Mike Mattson
Analyst, Needham
Yuan Ji
Analyst, B. Riley Securities
Mark Massaro
Analyst, BTIG
Mason Carrico
Analyst, Stevens
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Insight Molecular Diagnostics Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.316 Welcome, everyone, and thank you for joining us to discuss OncoSight's first quarter 00:00:04.316 -- 00:00:06.799 2025 results. 00:00:06.799 -- 00:00:11.644 If you have not seen today's shareholder letter, please visit OncoSight's investor relations 00:00:11.644 -- 00:00:14.645 page at investors.oncosight.com. 00:00:15.929 -- 00:00:21.395 Today's prepared remarks build upon the information already shared in this robust letter. 00:00:21.395 -- 00:00:26.681 Joining us today are OncoSight President and CEO Josh Riggs, Chief Science 00:00:26.681 -- 00:00:31.702 Officer Eki Schutz, and CFO Andrea James. We also have 00:00:31.702 -- 00:00:37.011 our analysts with us as panelists. After our prepared remarks, our analysts 00:00:37.011 -- 00:00:39.155 may ask questions. 00:00:39.155 -- 00:00:43.944 Before turning the call over to Josh Riggs, I'd like to go over our safe harbor. 00:00:43.944 -- 00:00:49.093 The company will make projections and forward-looking statements regarding future events. 00:00:49.093 -- 00:00:53.845 Any statements that are not historical facts are forward-looking statements. 00:00:53.845 -- 00:00:59.473 These statements are made pursuant to and within the meaning of the safe harbor provision 00:00:59.473 -- 00:01:04.157 of the Private Securities Litigation Reform Act of 1995. 00:01:04.160 -- 00:01:09.328 We encourage you to review the company's SEC filings, including the company's most 00:01:09.328 -- 00:01:14.556 recent form 10-K and subsequent forms 10-Q, which identify risks 00:01:14.556 -- 00:01:20.805 and uncertainties that may cause future actual results or events to differ materially. 00:01:20.805 -- 00:01:25.977 On this note, but the forward-looking statements made during today's call speak 00:01:25.977 -- 00...